Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.67 |
| ▸ | NPY1R | P25929 | 1/20 | 0.67 |
| ▸ | NPY2R | P49146 | 1/20 | 0.67 |
| ▸ | NPY4R | P50391 | 1/20 | 0.67 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.67 |
| ▸ | GLP1R | P43220 | 13/20 | 0.67 |
| ▸ | GIPR | P48546 | 7/20 | 0.64 |
| ▸ | CALCA | P06881 | 2/20 | 0.64 |
| ▸ | GCGR | P47871 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28972123 | 0.98 | KEAP1 (0.69) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| Cecropin Ad SCHEMBL29842479 | 0.97 | NPY1R (0.68) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30495604 | 0.92 | GLP1R (0.71) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31182815 | 0.92 | NPY2R (0.73) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29949636 | 0.92 | NPY1R (0.71) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| Cecropin B SCHEMBL29355118 | 0.92 | KEAP1 (0.69) | KEAP1GLP1RGCGR | |
| SCHEMBL31182745 | 0.91 | NPY1R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL29412272 | 0.91 | CXCR4 (0.66) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29352195 | 0.91 | NPY2R (0.70) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL31182544 | 0.91 | NPY1R (0.69) | KEAP1NPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 746 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101236-A1 | PEPTIDES SPECIFICALLY BINDING TO CCR8, AND USE THEREOF | 경희대학교 산학협력단 | 2026-05-15 | — | — | WO | claimed |
| EP-4074831-B1 | NOVEL POLYPEPTIDE, FUSION POLYPEPTIDE, AND ANTIBIOTIC AGAINST GRAM-NEGATIVE BACTERIA COMPRISING SAME | LYSENTECH CO LTD (KR) | 2026-01-21 | — | — | EP | claimed |
| EP-4677075-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR Biome ApS (DK) | 2026-01-14 | — | — | EP | claimed |
| US-20260000782-A1 | ITGB2-MEDIATED DRUG DELIVERY SYSTEM | TWINPIG BIOLAB INC. (KR) | 2026-01-01 | — | — | US | claimed |
| US-20250228951-A1 | NOVEL-PEPTIDE-BASED ANTICANCER IMMUNOTHERAPEUTIC AGENT | TWINPIG BIOLAB INC. (KR) | 2025-07-17 | — | — | US | claimed |
| CN-115925981-B | Antibacterial peptide for specific targeting of gram-negative bacteria and application thereof | 河南工业大学 | 2025-05-23 | — | — | CN | claimed |
| WO-2025106551-A1 | HYDROGEL COMPOSITIONS COMPRISING SYNERGISTIC ANTIMICROBIAL PEPTIDES (AMPS) AND METHODS OF MAKING SAME | ROWAN UNIVERSITY (US) | 2025-05-22 | — | — | WO | claimed |
| CN-112689758-B | Device and method for checking the effect of a drug on microorganisms | 上海宜晟生物科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119619105-A | Analysis method of surface enhanced Raman spectrum three-dimensional code on complex system and application thereof | 中国人民解放军陆军军医大学第一附属医院 | 2025-03-14 | — | — | CN | claimed |
| EP-4512411-A2 | ITGB2-MEDIATED DRUG DELIVERY SYSTEM | Twinpig Biolab, Inc. (KR) | 2025-02-26 | — | — | EP | claimed |
| EP-4074831-A1 | NOVEL POLYPEPTIDE, FUSION POLYPEPTIDE, AND ANTIBIOTIC AGAINST GRAM-NEGATIVE BACTERIA COMPRISING SAME | Lysentech Co., Ltd. (KR) | 2022-10-19 | — | — | EP | claimed |
| WO-2022204806-A1 | SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY | FELDAN BIO INC. (CA) | 2022-10-06 | — | — | WO | claimed |
| EP-3129044-B1 | PEPTIDOGLYCAN HYDROLASE FOR USE IN THE TREATMENT OF CHRONIC BACTERIAL INFECTIONS | LYSANDO AG (LI) | 2022-09-07 | — | — | EP | claimed |
| CN-113384737-B | Imbibition controlled-release antibacterial peptide hydrogel double-layer dressing and preparation method and application thereof | 重庆理工大学 | 2022-08-23 | — | — | CN | claimed |
| CN-114747674-A | Opening material for preventing lamb diarrhea and ewe mastitis | 榆阳区畜牧技术推广站 | 2022-07-15 | — | — | CN | claimed |
| CN-114569488-A | Antibacterial peptide modified nanocellulose hydrogel, preparation method and application thereof | 宁波糖聚新材料有限责任公司 | 2022-06-03 | — | — | CN | claimed |
| CN-107636017-B | Polypeptide-based shuttle agents for improving the efficiency of transduction of a polypeptide cargo into the cytoplasm of a target eukaryotic cell, uses thereof, and methods and kits related thereto | 费尔丹生物公司 | 2022-05-31 | — | — | CN | claimed |
| WO-2022082315-A1 | SHUTTLE AGENT PEPTIDES OF MINIMAL LENGH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS | FELDAN BIO INC. (CA) | 2022-04-28 | — | — | WO | claimed |
| WO-2022077121-A1 | PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION | FELDAN BIO INC. (CA) | 2022-04-21 | — | — | WO | claimed |
| CN-114106937-A | Contact lens care solution | 东南大学 | 2022-03-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000782-A1 | ITGB2-MEDIATED DRUG DELIVERY SYSTEM | ITGB8, ITGB2, ITGA8 | KEAP1 4549/4885NPY1R 2099/4885NPY2R 751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.